Prolia Overdosage

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Thai FDA Category Presentation/Packing Brand Resources

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Overdosage

No data from clinical trials are available regarding overdosage of PROLIA.
Denosumab has been administered in clinical studies using doses up to 180 mg every 4 weeks (cumulative doses up to 1,080 mg over 6 months) and no additional adverse effects were observed.

denosumab

Manufacturer:

Amgen

Distributor:

Zuellig Pharma